Noile-Immune Biotech Inc.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
Noile-Immune Biotech Inc.
Noile-Immune Biotech Inc. (ノイルイミューン・バイオテック株式会社, 4893), Pharmaceutical. A board of 8 and 10 largest shareholders, as filed on EDINET for the year to December 2025. EDINET filing S100XSP4, filed 2026-03-23. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2021-12-31 | 0.1 | −0.8 | 4.3 | −20.75 | — | 14 |
| 2022-12-31 | 0.6 | −0.4 | 4.6 | −9.87 | — | 19 |
| 2023-12-31 | 0.3 | −1.1 | 5.8 | −27.25 | — | 28 |
| 2024-12-31 | 0.0 | −1.0 | 4.8 | −22.28 | — | 25 |
| 2025-12-31 | 0.0 | −0.8 | 4.0 | −18.33 | — | 23 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown